Innovation Pharmaceuticals (IPIX) Stock Overview

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.

IPIX Stock Information

Symbol

IPIX

Address

301 Edgewater PlaceWakefield, MA 01880United States

Founded

Trading hours

Website

https://www.ipharminc.com

Country

🇺🇸 United States

Phone Number

978 921 4125

Innovation Pharmaceuticals (IPIX) Price Chart

Innovation Pharmaceuticals Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.0003	N/A
Market Cap	$151.73K	N/A
Shares Outstanding	505.77M	0.38%
Employees	4.00	N/A
Shareholder Equity	2.04M	-56.89%

Valuation	2023	Change
P/E Ratio	-0.03	N/A
P/B Ratio	0.07	N/A

Growth	2023	Change
Return on Equity	-1.5537	N/A

Earnings	2023	Change
Revenue	$0	N/A
Earnings	-$3.17M	N/A
EPS	-0.01	N/A
Earnings Yield	-33.33	N/A

Financial Strength	2023	Change
Total Assets	$7.52M	N/A
Total Debt	$268.00K	N/A
Cash on Hand	$1.52M	N/A
Debt to Equity	$2.69	124.95%
Cash to Debt	$5.66	-25.31%
Current Ratio	0.3254	-60.41%